PAP21 inhibitors are a class of chemical compounds that target and modulate the activity of the enzyme PAP21, which is involved in post-transcriptional RNA processing. PAP21, or Poly(A) polymerase 21, plays a crucial role in the addition of polyadenylate (poly(A)) tails to the 3' end of mRNA molecules during the final stages of RNA synthesis. This polyadenylation process is essential for the stability, nuclear export, and translation of mRNA, as well as for the regulation of gene expression. By inhibiting PAP21, these compounds can disrupt the normal processing of mRNA, thereby affecting the stability and availability of mRNA molecules for protein synthesis.
The mechanism of PAP21 inhibitors involves binding to the active site of the enzyme, preventing it from catalyzing the addition of the poly(A) tail to nascent mRNA transcripts. This inhibition can lead to alterations in mRNA maturation, affecting the gene expression profile within cells. Researchers use PAP21 inhibitors as tools to study the broader effects of polyadenylation on mRNA metabolism, cellular function, and gene regulation. By blocking PAP21 activity, scientists can explore the intricate relationship between RNA processing and the control of protein synthesis, gaining insights into how cells maintain the balance of gene expression. These inhibitors also provide a means to investigate how dysregulation in mRNA polyadenylation impacts cellular processes such as differentiation, growth, and response to environmental signals, highlighting the importance of PAP21 in the overall control of gene expression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, potentially affecting proteins regulated by the PI3K/Akt pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
Inhibits MEK, which may alter the MAPK/ERK pathway that can modulate various proteins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAP kinase, potentially affecting proteins involved in the stress-activated MAPK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may impact proteins that are regulated by the JNK signaling pathway. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
Inhibits MEK1/2, potentially affecting proteins downstream of the ERK pathway. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Inhibits mTOR, potentially affecting proteins involved in the mTOR signaling pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, potentially affecting proteins regulated by the PI3K/Akt pathway. | ||||||
NF449 | 627034-85-9 | sc-478179 sc-478179A sc-478179B | 10 mg 25 mg 100 mg | $199.00 $460.00 $1479.00 | 1 | |
Inhibits Gs-alpha subunit, potentially affecting proteins regulated by G-protein signaling. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
Inhibits myosin light chain kinase, potentially affecting proteins associated with cytoskeletal regulation. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
Chelates intracellular calcium, potentially affecting proteins regulated by calcium signaling. | ||||||